Among the breast cancer molecular subtypes, triple negative breast cancer (TNBC), accounting for 15–20% of all breast cancers, is defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (Her-2) expression (1). The gene discussed is PGR; the disease is triple-negative breast carcinoma.